What will the AOTMiT Transparency Council address at its upcoming meeting?

The agenda includes:

1. Preparation of a position paper on the evaluation of the drug Flutixon Nasal (azelastini hydrochloridum + fluticasone propionas), for the indication: relief of symptoms of seasonal and year-round allergic rhinosinusitis of moderate to severe severity, if the use of other intranasally administered products containing only an antihistamine or a glucocorticosteroid is considered insufficient.
2. Preparation of a position paper on the evaluation of the drug Vyloy (zolbetuximab) under drug program B.58"Treatment of patients with cancer of the esophagus, gastroesophageal junction and stomach (ICD-10: C15-C16)".
3. Preparation of a position paper on the evaluation of the drug Darzalex (daratumumabum) under drug program B.54 "Treatment of patients with plasmocytic myeloma (ICD-10: C90.0)".
4. Preparation of a position paper on the evaluation of the drug Carvykti (ciltacabtagene autoleucel) under drug program B.54 "Treatment of patients with plasmocytic myeloma (ICD-10: C90.0)".
5. Preparation of a position paper on the evaluation of the drug Imfinzi (durvalumabum) under drug program B.6"Treatment of patients with lung cancer (ICD-10: C34) and pleural mesothelioma (ICD-10: C45)".
6. Preparation of a position paper on the examination of the legitimacy of issuing approvals for reimbursement of the foodstuff for special nutritional use Paediatric Seravit for the indications:
   - deficiency of very long-chain fatty acid dehydrogenase (VLCAD),
   - isovalerian acidaemia.
7. Preparation of a position paper on examining the appropriateness of issuing reimbursement approvals for the medicinal product Trulance (plecanatide) for the indication: constipation in patients with pelvic floor dyssynergia.
8. Preparation of a position paper on examining the appropriateness of issuing reimbursement approvals for the medicinal product Xuriden (uridine triacetate) for the indication: uridine monophosphate synthase enzyme deficiency.

Source: AOTMiT